Steffen Appold

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness

Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons

Elastomeric high‐mineral content hydrogel‐hydroxyapatite composites for orthopedic applications

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making

PET in the management of locally advanced and metastatic NSCLC

The biology and management of non-small cell lung cancer

Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective

Machine Learning methods for Quantitative Radiomic Biomarkers

Oral complications of cancer and cancer therapy

Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology

Influence of connective tissue diseases on the expression of radiation side effects: A systematic review

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Nasopharyngeal carcinoma

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription

Individualization of cancer treatment from radiotherapy perspective

The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer

Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma

‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Radiomics: Extracting more information from medical images using advanced feature analysis

Radiomics: the bridge between medical imaging and personalized medicine

A palliative accelerated irradiation regimen for advanced non–small-cell lung cancer VS. conventionally fractionated 60 GY: results of a randomized equivalence study

Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

Dissemination and publication of research findings: an updated review of related biases

Joint contact stress: a reasonable surrogate for biological processes?

Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy

Machine Learning in Agriculture: A Review

Cancer Stem Cells: Targets and Potential Biomarkers for Radiotherapy

American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

Effects of radiotherapy on olfactory function

Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

Support Vector Machine-Based Prediction of Local Tumor Control After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Radiobiological Hypoxia, Oxygen Tension, Interstitial Fluid Pressure and Relative Viable Tumour Area in Two Human Squamous Cell Carcinomas in Nude Mice During Fractionated Radiotherapy

GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial

Ergebnisse der bestrahlung inoperabler nichtkleinzelliger bronchialkarzinome im stadium III mit 25 Gy in fünf fraktionen

Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer

Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer